Literature DB >> 27476064

A study to investigate the factors that influence the prescribing habits of non-consultant hospital doctors in Ireland.

B Ramasubbu1, M Heron2, R Ramasubbu3, P Murphy4.   

Abstract

BACKGROUND: The Health Service Executive estimates it spent just under €2 billion on medicines in 2013 following a fivefold increase in the cost of medicines over the preceding decade. With this increasing cost, it is important to understand what factors affect doctors prescribing. AIMS: To investigate the influencing factors on prescribing of non-consultant hospital doctors (NCHDs) in Irish hospitals and to provide data regarding the sources of information NCHD's use for commonly prescribed drugs.
METHODS: All medical manpower offices of adult public hospitals in the Republic of Ireland were emailed with our survey for distribution to NCHDs. It contained demographic information and questions regarding factors which most influence their prescribing of particular drug groups. Tests of significance were carried out using Chi-square.
RESULTS: One hundred and seventy-nine surveys were returned out of a possible 8987 (0.02 %). Consultant preference was the biggest overall influencing factor on junior doctors prescribing (27 %). This was closely followed by local departmental policies (26 %). Evidence-based prescribing only influenced 14 % of the total prescribing of NCHDs with the pharmaceutical representative influence only a fraction behind (13 %). Knowledge obtained during medical school greater influenced postgraduate prescribing than undergraduate (34 vs 14 %, p = 0.046). Registrars were significantly more likely to prescribe using evidence-based medicine than intern and SHOs (p = 0.03).
CONCLUSIONS: The prescription of medications in Ireland by NCHDs varies greatly depending not only on drug group, but it is also affected by the doctors' previous education and experience. This information is key in leading to sensible cost-effective prescribing.

Keywords:  Influencing factors; Non-consultant hospital doctors; Pharmaceutical representative; Prescribing

Mesh:

Year:  2016        PMID: 27476064     DOI: 10.1007/s11845-016-1486-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  11 in total

Review 1.  Origins and evolution of antibiotic resistance.

Authors:  Julian Davies; Dorothy Davies
Journal:  Microbiol Mol Biol Rev       Date:  2010-09       Impact factor: 11.056

2.  Are graduate entry programmes the answer to recruiting and selecting tomorrow's doctors?

Authors:  David Powis; John Hamilton; Jill Gordon
Journal:  Med Educ       Date:  2004-11       Impact factor: 6.251

3.  Graduate entry to medical school.

Authors:  Ann Jervie Sefton
Journal:  Med Educ       Date:  2004-11       Impact factor: 6.251

4.  Cost effectiveness of statin therapy for the primary prevention of coronary heart disease.

Authors:  V Walshe; A Nash; M Barry
Journal:  Ir Med J       Date:  2006-05

5.  The journal club and medical education: over one hundred years of unrecorded history.

Authors:  M Linzer
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

6.  Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme.

Authors:  B McGowan; K Bennett; L Tilson; M Barry
Journal:  Ir Med J       Date:  2005-03

7.  The impact of evidence on physicians' inpatient treatment decisions.

Authors:  Brian P Lucas; Arthur T Evans; Brendan M Reilly; Yuri V Khodakov; Kalyani Perumal; Louis G Rohr; Joseph A Akamah; Tunji M Alausa; Christopher A Smith; Jeremy P Smith
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

8.  Proton pump inhibitors: potential cost reductions by applying prescribing guidelines.

Authors:  Caitriona Cahir; Tom Fahey; Lesley Tilson; Conor Teljeur; Kathleen Bennett
Journal:  BMC Health Serv Res       Date:  2012-11-19       Impact factor: 2.655

Review 9.  The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use.

Authors:  Mohamed Azmi Hassali; Alian A Alrasheedy; Andrew McLachlan; Tuan Anh Nguyen; Saleh Karamah Al-Tamimi; Mohamed Izham Mohamed Ibrahim; Hisham Aljadhey
Journal:  Saudi Pharm J       Date:  2013-12-25       Impact factor: 4.330

10.  Generic medicines and generic substitution: contrasting perspectives of stakeholders in Ireland.

Authors:  A O'Leary; C Usher; M Lynch; M Hall; L Hemeryk; S Spillane; P Gallagher; M Barry
Journal:  BMC Res Notes       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.